Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 4
1989 1
1990 1
1993 1
1997 1
1998 1
2006 2
2007 1
2011 2
2013 1
2014 2
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Bryan LJ, Casulo C, Allen PB, Smith SE, Savas H, Dillehay GL, Karmali R, Pro B, Kane KL, Bazzi LA, Chmiel JS, Palmer BA, Mehta J, Gordon LI, Winter JN. Bryan LJ, et al. Among authors: dillehay gl. JAMA Oncol. 2023 May 1;9(5):683-691. doi: 10.1001/jamaoncol.2022.7975. JAMA Oncol. 2023. PMID: 36928527 Free PMC article. Clinical Trial.
Nuclear medicine practitioner competencies.
Owen MA, Pickett MW, Christian PE, Dillehay GL, Fulk LA, Gordon LL, Henkin RE, Hess-Smith M, Hubble WL, Hunt KT, Keech FK, Nielsen C, Stachowiak A; SNMTS Advanced Practice Task Force. Owen MA, et al. Among authors: dillehay gl. J Nucl Med Technol. 2007 Mar;35(1):39-41. J Nucl Med Technol. 2007. PMID: 17337656 Free article. No abstract available.
Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
Dillehay GL, Ellerbroek NA, Balon H, Brill DR, Grigsby PW, Macklis RM, Mauch PM, Mian TA, Potters L, Silberstein EB, Williams TR, Wong JC, Gaspar LE; American Society for Therapeutic Radiology and Oncology. Dillehay GL, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1299-307. doi: 10.1016/j.ijrobp.2005.11.003. Epub 2006 Feb 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16472933 No abstract available.
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gentzler RD, Evens AM, Rademaker AW, Weitner BB, Mittal BB, Dillehay GL, Petrich AM, Altman JK, Frankfurt O, Variakojis D, Singhal S, Mehta J, Williams S, Kaminer L, Gordon LI, Winter JN. Gentzler RD, et al. Among authors: dillehay gl. Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15. Br J Haematol. 2014. PMID: 24628515 Free article.
ABNM position statement: Nuclear medicine professional competency and scope of practice.
Frey KA, Royal HD, Di Carli MF, Dillehay GL, Gordon L, Mankoff DA, O'Malley J, Ramanna L, Rohren E, Segall GM, Shulkin BL, Wallis JW, Ziessman HA. Frey KA, et al. Among authors: dillehay gl. J Nucl Med. 2011 Jun;52(6):994-7. doi: 10.2967/jnumed.111.089979. Epub 2011 May 13. J Nucl Med. 2011. PMID: 21571802 Free article. No abstract available.
21 results